Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|16|1903-1913

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.16, 2006-07, pp. : 1903-1913

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses

By  

Current Pharmaceutical Design, Vol. 14, Iss. 30, 2008-10 ,pp. : 3219-3230

Bentham Science Publishers

Access to resources Recommend Favorite

Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 587-596

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular and Cellular Pathways as a Target of Therapeutic Hypothermia: Pharmacological Aspect

By  

Current Neuropharmacology, Vol. 10, Iss. 1, 2012-03 ,pp. : 80-87

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Pathways in Breast Cancer: Molecular and Protein Markers Guiding Therapeutic Decisions

By  

Current Molecular Pharmacology, Vol. 7, Iss. 1, 2014-04 ,pp. : 4-21

Bentham Science Publishers

Access to resources Recommend Favorite

Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-01 ,pp. : 1867-1880

Bentham Science Publishers

Access to resources Recommend Favorite